768
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Is apremilast a treatment for SAPHO syndrome?

, , , , , & show all
Article: 2300743 | Received 25 Dec 2023, Accepted 26 Dec 2023, Published online: 17 Jan 2024

References

  • Milakovic M, Gooderham MJ. Phosphodiesterase-4 inhibition in psoriasis. Psoriasis (Auckl). 2021;11:1–3. doi:10.2147/PTT.S303634.
  • Spencer RK, Elhage KG, Jin JQ, et al. Apremilast in palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and meta-analysis. Dermatol Ther (Heidelb). 2023;13(2):437–451. doi:10.1007/s13555-022-00877-w.
  • Adamo S, Nilsson J, Krebs A, et al. Successful treatment of SAPHO syndrome with apremilast. Br J Dermatol. 2018;179(4):959–962. doi:10.1111/bjd.16071.
  • Li C, Wang H, Jiang H, et al. Family aggregation and prevalence of other autoimmune diseases in SAPHO syndrome. Heliyon. 2023;9:e21541. doi:10.1016/j.heliyon.2023.e21541
  • Cheng W, Li F, Tian J, et al. New insights in the treatment of SAPHO syndrome and medication recommendations. J Inflamm Res. 2022;15:2365–2380. doi:10.2147/JIR.S353539.
  • Yue Q, Ma M, Liu S, et al. JAKi: can it be used to treat SAPHO syndrome? Int J Rheum Dis. 2023. doi:10.1111/1756-185X.14930.
  • Jiang H, Lv L, Lin Z, et al. SAPHO syndrome can cause sausage finger lesions. RMD Open. 2023;9(3):e003335. doi:10.1136/rmdopen-2023-003335.
  • Peris P, Monegal A, Guañabens N. Bisphosphonates in inflammatory rheumatic diseases. Bone. 2021;146:115887. doi:10.1016/j.bone.2021.115887.
  • Li C, Zhao Y, Zuo Y, et al. Efficacy of bisphosphonates in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a prospective open study. Clin Exp Rheumatol. 2019;37(4):663–669.
  • Wu N, Zhao Y, Tao W, et al. A single cohort, open-label study of the efficacy of pamidronate for palmoplantar pustulosis in synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome. Clin Exp Rheumatol. 2020;38(6):1263–1264.
  • Wang CR, Tsai YS, Whang-Peng J. Zoledronic acid monotherapy improves osteoarticular involvement in SAPHO syndrome. Scand J Rheumatol. 2020;49(5):419–421. doi:10.1080/03009742.2020.1769179.
  • Rodriguez-García SC, Castellanos-Moreira R, Muxí A, et al. Imaging follow-up of SAPHO syndrome treated with zoledronic acid. J Clin Rheumatol. 2020;26(6):e155–e157. doi:10.1097/RHU.0000000000001025.
  • Liu S, Yin D, Lin Z, et al. Short-term efficacy of zoledronic acid in the treatment of 30 cases of SAPHO syndrome. Clin Exp Rheumatol. 2023. doi:10.55563/clinexprheumatol/zpgyz9.